Skip to main content

Eli Lilly Takes Perpetual License to Entelos' DrugMatrix Database

NEW YORK (GenomeWeb News) – Entelos said today that Eli Lilly has purchased a perpetual license to its DrugMatrix toxicogenomics database.
 
Under the terms of the agreement, Lilly will make a one-time payment to Entelos for a perpetual license to the database and customized report services from the company’s ToxFx business, with the option for continued support.
 
Financial terms were not disclosed.
 
Entelos, a biosimulation firm that develops "virtual humans" to help predict drug response, picked up the DrugMatrix database in its acquisition of Iconix last August.
 
The database is a reference set of gene expression profiles for benchmark drugs and compounds that are linked to pharmacology, toxicology, and clinical pathology measurements. It currently includes profiles from more than 630 different compounds.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.